Boston Scientific Return on Investment 2006-2018 | BSX

Current and historical return on investment (ROI) values for Boston Scientific (BSX) over the last 10 years.
Boston Scientific ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2018-12-31 $1.51B $13.53B 11.81%
2018-09-30 $1.51B $13.10B 12.48%
2018-06-30 $1.50B $12.55B 12.67%
2018-03-31 $1.33B $11.83B 11.38%
2017-12-31 $1.29B $10.83B 10.83%
2017-09-30 $1.11B $12.00B 9.07%
2017-06-30 $1.08B $12.05B 8.90%
2017-03-31 $0.52B $12.56B 4.34%
2016-12-31 $0.45B $12.15B 3.80%
2016-09-30 $0.08B $11.65B 0.68%
2016-06-30 $-0.57B $11.39B -4.78%
2016-03-31 $-0.01B $11.88B -0.12%
2015-12-31 $-0.28B $11.99B -2.45%
2015-09-30 $-0.55B $12.21B -4.93%
2015-06-30 $-0.19B $11.65B -1.72%
2015-03-31 $-0.47B $10.35B -4.47%
2014-12-31 $-0.30B $10.30B -2.81%
2014-09-30 $0.32B $10.95B 2.95%
2014-06-30 $0.36B $10.80B 3.32%
2014-03-31 $0.65B $10.78B 6.07%
2013-12-31 $0.12B $10.78B 1.13%
2013-09-30 $0.11B $10.81B 1.02%
2013-06-30 $-0.59B $10.25B -5.43%
2013-03-31 $-4.39B $10.75B -39.11%
2012-12-31 $-3.87B $11.12B -31.05%
2012-09-30 $-3.81B $11.08B -28.08%
2012-06-30 $-3.05B $11.98B -20.64%
2012-03-31 $0.78B $15.65B 4.96%
2011-12-31 $0.90B $15.61B 5.72%
2011-09-30 $1.08B $15.78B 6.78%
2011-06-30 $1.16B $15.74B 7.22%
2011-03-31 $1.15B $16.04B 7.14%
2010-12-31 $-0.66B $16.23B -4.04%
2010-09-30 $-2.24B $16.17B -13.36%
2010-06-30 $-2.44B $16.08B -13.95%
2010-03-31 $-2.39B $16.45B -13.09%
2009-12-31 $-0.89B $18.22B -4.70%
2009-09-30 $-2.08B $19.07B -10.68%
2009-06-30 $-2.10B $19.33B -10.35%
2009-03-31 $-2.07B $19.52B -9.81%
2008-12-31 $-1.51B $19.92B -6.86%
2008-09-30 $0.48B $22.46B 2.12%
2008-06-30 $0.31B $22.65B 1.34%
2008-03-31 $0.28B $22.70B 1.22%
2007-12-31 $-0.01B $23.03B -0.06%
2007-09-30 $0.70B $23.42B 2.91%
2007-06-30 $1.04B $24.05B 4.31%
2007-03-31 $-3.16B $24.45B -13.14%
2006-12-31 $-2.95B $24.19B -15.05%
2006-09-30 $-2.77B $23.91B -18.35%
2006-06-30 $-3.30B $23.78B -30.86%
2006-03-31 $0.95B $6.51B 15.41%
2005-12-31 $0.97B $6.15B 16.33%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $52.874B $9.823B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.623B 27.80
Medtronic (MDT) Ireland $123.520B 18.06
Stryker (SYK) United States $73.875B 27.09
Baxter (BAX) United States $40.209B 25.72
Zimmer Biomet Holdings (ZBH) United States $26.486B 16.96
Smith & Nephew SNATS (SNN) United Kingdom $17.634B 0.00
Canopy Growth (CGC) Canada $15.407B 0.00
ResMed (RMD) United States $14.469B 27.44
Aurora Cannabis (ACB) Canada $9.687B 68.36
Bio-Rad Laboratories (BIO) United States $9.455B 53.94
Hill-Rom Holdings (HRC) United States $7.140B 22.08
Perrigo (PRGO) Ireland $6.601B 10.70
Insulet (PODD) United States $6.039B 2037.40
GW Pharmaceuticals (GWPH) United Kingdom $5.309B 0.00
ICU Medical (ICUI) United States $4.841B 30.14
Haemonetics (HAE) United States $4.496B 39.88
Hutchison China MediTech (HCM) China $3.961B 0.00
Agios Pharmaceuticals (AGIO) United States $3.830B 0.00
Neogen (NEOG) United States $3.332B 51.18
NuVasive (NUVA) United States $2.927B 25.53
Quidel (QDEL) United States $2.672B 24.11
Aphria (APHA) $2.518B 111.78
National Vision Holdings (EYE) United States $2.327B 45.77
HEXO (HEXO) $1.429B 0.00
Cardiovascular Systems (CSII) United States $1.402B 1006.25
Phibro Animal Health (PAHC) United States $1.308B 18.80
VAREX IMAGING (VREX) United States $1.299B 25.44
AtriCure (ATRC) United States $1.104B 0.00
Lantheus Holdings (LNTH) United States $0.968B 26.15
MacroGenics (MGNX) United States $0.967B 0.00
Cerus (CERS) United States $0.885B 0.00
PetIQ (PETQ) United States $0.872B 24.96
Omeros (OMER) United States $0.868B 0.00
NanoString Technologies (NSTG) United States $0.753B 0.00
Meridian Bioscience (VIVO) United States $0.727B 21.67
OraSure Technologies (OSUR) United States $0.713B 31.24
Eagle Pharmaceuticals (EGRX) United States $0.705B 23.99
Evolus (EOLS) United States $0.701B 0.00
TG Therapeutics (TGTX) United States $0.650B 0.00
Surmodics (SRDX) United States $0.618B 89.94
LeMaitre Vascular (LMAT) United States $0.614B 29.21
Quanterix (QTRX) United States $0.551B 0.00
BioLife Solutions (BLFS) United States $0.397B 163.54
Vapotherm (VAPO) United States $0.371B 0.00
Rockwell Medical (RMTI) United States $0.363B 0.00
Insys Therapeutics (INSY) United States $0.358B 0.00
Utah Medical Products (UTMD) United States $0.312B 20.30
Owens & Minor (OMI) United States $0.284B 3.94
Bovie Medical (APYX) United States $0.264B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.257B 0.00
Cytosorbents (CTSO) United States $0.255B 0.00
Zynex (ZYXI) United States $0.143B 15.35
Fonar (FONR) United States $0.143B 7.64
Surface Oncology (SURF) United States $0.117B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.088B 0.00
United-Guardian (UG) United States $0.087B 20.01
CAS Medical Systems (CASM) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Neurotrope (NTRP) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
Senestech (SNES) United States $0.028B 0.00
Myomo (MYO) United States $0.022B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.009B 15.57